Cardlytics, Inc. — Director's Dealing 2023

Aug 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2023-08-07

Reporting Person: Lynton Nicholas Hollmeyer (Chief Legal & Privacy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-07	Common Stock	S	4957	$13.48	Disposed	37151	Direct
2023-08-07	Common Stock	S	165	$14.05	Disposed	36986	Direct
2023-08-09	Common Stock	S	7500	$13.67	Disposed	29486	Direct

Footnotes

F1: Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on April 1, 2023, April 2, 2023 and April 20, 2023.

F2: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.

F3: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.11, inclusive.

F4: The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.66 to $13.77, inclusive.